Comparison of recombinant human erythropoietin and darbepoetin alpha in children

Pediatrics International

Volumn 55, Issue 3, 2013, Pages 296-299

  Can, Ceren ^a   Emre, Sevinç ^a   Bilge, Ilmay ^a   Yilmaz, Alev ^a   Şirin, Aydan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

anemia; child; chronic kidney disease; darbepoetin alpha; recombinant human erythropoietin

Indexed keywords

FERRITIN; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; ANTIANEMIC AGENT; ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ANEMIA; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; COMPARATIVE STUDY; COMPLICATION; DOSE RESPONSE; DRUG ADMINISTRATION; HEMOGLOBIN DETERMINATION; KIDNEY FAILURE, CHRONIC; PRESCHOOL CHILD; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

ADOLESCENT; ANEMIA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HEMATINICS; HEMOGLOBINOMETRY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS; RECOMBINANT PROTEINS; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 84879397893     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12085     Document Type: Conference Paper

References (18)

1. Warady BA, Arar MY, Lerner G, Nakanishi AM, Stehman-Breen C,. Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease. Pediatr. Nephrol. 2006; 21: 1144-1152.
2. Koshy SM, Geary DF,. Anemia in children with chronic kidney disease. Pediatr. Nephrol. 2008; 23: 209-219.
3. Morris KP, Skinner JR, Hunter S, Coulthard MG,. Cardiovascular abnormalities in end stage renal failure: The effect of anaemia or uraemia? Arch. Dis. Child. 1994; 71: 119-122.
4. Morris KP, Sharp J, Watson S, Coulthard MG,. Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia. Arch. Dis. Child. 1993; 69: 580-586.
5. Jabs K,. The effects of recombinant human erythropoietin on growth and nutritional status. Pediatr. Nephrol. 1996; 10: 324-327.
6. VanDeVoorde RG, Warady BA,. Management of chronic kidney disease. In:, Avner ED, Harmon WE, Niaudet P, Yoshikawa N, (eds). Pediatric Nephrology, 6th edn. Springer-Verlag, Berlin, 2009; 1661-1692.
7. Lerner G, Kale AS, Warady G, et al,. Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease. Pediatr. Nephrol. 2002; 17: 933-937.
8. Nissenson AR,. Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease. Am. J. Kidney Dis. 2001; 38: 1390-1397.
9. Toto RD, Pichette V, Navarro J, et al,. Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration. Am. J. Nephrol. 2004; 24: 453-460.
10. Suranyi MG, Lindberg JS, Navarro J, Elias C, Brenner RM, Walker R,. Treatment of anemia with darbepoetin alfa administered de novo once every other week in chronic kidney disease. Am. J. Nephrol. 2003; 23: 106-111.
11. Ling B, Walczyk M, Agarwal A, Carroll W, Liu W, Brenner R,. Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease. Clin. Nephrol. 2005; 63: 327-334.
12. De Palo T, Giordano M, Palumbo F, et al,. Clinical experience with darbepoetin alfa (NESP) in children undergoing hemodialysis. Pediatr. Nephrol. 2004; 19: 337-340.
13. Durkan AM, Keating LE, Vigneux A, Geary DF,. The use of darbepoetin in infants with chronic renal impairment. Pediatr. Nephrol. 2006; 21: 694-697.
14. Geary DF, Keating LE, Vigneux A, Stephens D, Hébert D, Harvey EA,. Darbepoetin alfa (Aranesp) in children with chronic renal failure. Kidney Int. 2005; 68: 1759-1765.
15. André JL, Deschênes G, Boudailliez B, et al,. Darbepoetin, effective treatment of anaemia in paediatric patients with chronic renal failure. Pediatr. Nephrol. 2007; 22: 708-714.
16. Schmitt CP, Nau B, Brummer C, Rosenkranz J, Schaefer F,. Increased injection pain with darbepoetin-alpha compared to epoetin-beta in paediatric dialysis patients. Nephrol. Dial. Transplant. 2006; 21: 3520-3524.
17. Macdougall IC,. An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP). Nephrol. Dial. Transplant. 2001; 3: 14-21.
18. Hertel JEW, Locay HR, Scarlata DS, Prathikanti R, Audhya PK,. Darbepoetin alfa administration to achieve and maintain target hemoglobin levels for 1 year in patients with chronic kidney disease. Mayo Clin. Proc. 2006; 81: 1188-1194.